QL1706 With Chemotherapy Shows Disease Control in Rare Ureteral Cancer Case
A clinical case report found that third-line treatment with the bifunctional PD-1/CTLA-4 product QL1706 and chemotherapy achieved eight months of ...
A clinical case report found that third-line treatment with the bifunctional PD-1/CTLA-4 product QL1706 and chemotherapy achieved eight months of ...
Clinicians have documented the first reported case of cadonilimab-associated hemophagocytic lymphohistiocytosis in a cervical cancer patient who experienced relapse during ...
A comprehensive review analyzes how platinum chemotherapy has evolved across three generations to treat cervical cancer alongside emerging nanotechnology systems ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.